Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke · 2001
[Lamotrigine in the treatment of mental disorders].
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Malt U F, Fladvad T
Аннотация
BACKGROUND: Bipolar and other mood disorders often do not respond satisfactorily to lithium, valproate, carbamazepine or antidepressants.
MATERIAL AND METHODS: On the basis of six years of clinical experience with lamotrigine in the treatment of psychiatric disorders, supplemented by three case reports and a comprehensive literature review of empirical studies, we discuss the possible indications for lamotrigine in psychiatric disorders.
RESULTS: Lamotrigine seems to have a stronger antidepressant effect in bipolar 1 disorders than gabapentine, carbamazepine and valproate, but a weaker effect on manic symptomatology than the latter two. Lamotrigine may be of value in the treatment of bipolar 2 disorders in which chronic treatment resistant depression is often a complication, including rapid cycling and, in the unipolar version of rapid cycling, brief recurrent depression. We have also used to good effect the neuroprotective effects of lamotrigine in prophylactic treatment of neurodegenerative disorders (e.g. Huntington's chorea).
INTERPRETATION: Lamotrigine is an anticonvulsant with an efficacy profile in psychiatric disorders different from those of valproate, carbamazepine and gabapentine. The drug represents an important supplement to the treatment options in chronic recurrent mood and neuropsychiatric disorders.
MATERIAL AND METHODS: On the basis of six years of clinical experience with lamotrigine in the treatment of psychiatric disorders, supplemented by three case reports and a comprehensive literature review of empirical studies, we discuss the possible indications for lamotrigine in psychiatric disorders.
RESULTS: Lamotrigine seems to have a stronger antidepressant effect in bipolar 1 disorders than gabapentine, carbamazepine and valproate, but a weaker effect on manic symptomatology than the latter two. Lamotrigine may be of value in the treatment of bipolar 2 disorders in which chronic treatment resistant depression is often a complication, including rapid cycling and, in the unipolar version of rapid cycling, brief recurrent depression. We have also used to good effect the neuroprotective effects of lamotrigine in prophylactic treatment of neurodegenerative disorders (e.g. Huntington's chorea).
INTERPRETATION: Lamotrigine is an anticonvulsant with an efficacy profile in psychiatric disorders different from those of valproate, carbamazepine and gabapentine. The drug represents an important supplement to the treatment options in chronic recurrent mood and neuropsychiatric disorders.